Soluble TWEAK levels are independently associated with coronary artery disease severity in patients with stage 2-3 kidney disease.
| Image |  |
|---|---|
| Description | scientific article published on 17 September 2013 |
| Author/s |
author: Alper Azak |
| Publication date | September 17, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |